Biotechnology Stocks
| # | Últimos 7 dias | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 119 | VRTX Vertex Pharmaceuticals Incorporated - Common Stock | 503.39 USD | -0.44% | -0.66% | -3.93% | +20.05% | 127.59 B USD | ||
| 211 | MRNA Moderna, Inc. - Common Stock | 197.20 USD | +0.37% | +4.38% | +40.56% | +603.78% | 78.73 B USD | ||
| 218 | REGN Regeneron Pharmaceuticals, Inc. - Common Stock | 739.50 USD | -0.35% | +0.64% | -8.00% | +29.96% | 76.14 B USD | ||
| 306 | ARGX argenx SE - American Depositary Shares | 817.80 USD | -11.92% | -12.63% | -17.53% | +2.67% | 50.61 B USD | ||
| 369 | RVMD Revolution Medicines, Inc. - Common Stock | 188.10 USD | -6.36% | -8.64% | -8.69% | +239.53% | 40.32 B USD | ||
| 446 | ALNY Alnylam Pharmaceuticals, Inc. - Common Stock | 224.53 USD | +0.05% | -2.82% | -12.46% | -50.22% | 30.04 B USD | ||
| 506 | RPRX Royalty Pharma plc - Class A Ordinary Shares | 56.21 USD | -0.97% | -2.46% | -7.24% | +50.86% | 25.10 B USD | ||
| 512 | ROIV Roivant Sciences Ltd. - Common Shares | 34.23 USD | -1.50% | -3.58% | -17.30% | +86.95% | 24.73 B USD | ||
| 530 | INCY Incyte Corporation - Common Stock | 112.73 USD | -0.63% | -3.76% | -9.38% | +31.77% | 22.85 B USD | ||
| 531 | UTHR United Therapeutics Corporation - Common Stock | 532.78 USD | -2.24% | -6.76% | +6.99% | +18.44% | 22.85 B USD | ||
| 539 | BNTX BioNTech SE - American Depositary Shares | 92.06 USD | -3.35% | -4.89% | -6.54% | -13.34% | 22.09 B USD | ||
| 551 | INSM Insmed Incorporated - Common Stock | 100.61 USD | -1.11% | -7.29% | -18.86% | -37.91% | 21.97 B USD | ||
| 684 | EXEL Exelixis, Inc. - Common Stock | 59.02 USD | +0.99% | +1.86% | +2.64% | +51.18% | 14.62 B USD | ||
| 700 | JAZZ Jazz Pharmaceuticals plc - Ordinary Shares | 222.45 USD | -3.78% | -4.53% | -6.70% | +58.89% | 14.44 B USD | ||
| 711 | ASND Ascendis Pharma A/S - American Depositary Shares | 222.63 USD | -2.53% | -1.93% | -17.15% | +8.56% | 13.80 B USD | ||
| 723 | SMMT Summit Therapeutics Inc. - Common Stock | 17.18 USD | -4.29% | +3.00% | -5.29% | -13.49% | 13.71 B USD | ||
| 752 | CORT Corcept Therapeutics Incorporated - Common Stock | 118.54 USD | -0.89% | +3.96% | +3.80% | +61.56% | 12.81 B USD | ||
| 766 | BBIO BridgeBio Pharma, Inc. - Common Stock | 65.04 USD | -2.20% | -2.79% | -11.67% | +14.11% | 12.71 B USD | ||
| 778 | HALO Halozyme Therapeutics, Inc. - Common Stock | 109.86 USD | -0.84% | +2.73% | +2.20% | +64.46% | 12.47 B USD | ||
| 822 | TECH Bio-Techne Corp - Common Stock | 72.47 USD | -0.08% | +0.08% | +0.24% | +19.67% | 11.36 B USD |
Notícias Biotechnology Stocks
Raymond James inicia cobertura da Nektar com classificação de desempenho de mercado
Ação da Palisade Bio inicia cobertura com Outperform na Raymond James
Raymond James mantém recomendação para ações da Liquidia em meio a processos judiciais
Ginkgo Bioworks vai apoiar o programa NSF X-Labs com acesso a laboratório
AbCellera apresentará dados de fase 1/2 sobre candidato a medicamento para menopausa
Quantum-Si detecta 19 aminoácidos no programa de desenvolvimento Proteus
Por que as ações da Revolution Medicines estão caindo hoje?
Gainers Biotechnology Stocks
GRDX GridAI Technologies Corp. - Common Stock | 4.79 | +16.26% |
CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
SRZN Surrozen, Inc. - Common Stock | 28.00 | +11.38% |
ANL Adlai Nortye Ltd - American Depositary Shares | 15.54 | +10.60% |
QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
ENLV Enlivex Ltd. - Ordinary Shares | 0.27 | -12.90% |
MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |